HeraMEDSTU:1I4 +5.00% Dividend Yield % is 0.00% as of Jun. 29, 2026. The stock has 2 warning signs investors should review. Among 329 Medical Devices & Instruments companies, HeraMED ranks worse than 303951.06% on this metric.
As of today (2026-06-29), the Trailing Annual Dividend Yield of HeraMED is 0.00%.
The historical rank and industry rank for HeraMED's Dividend Yield % or its related term are showing as below:
STU:1I4's Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.98 * Ranked among companies with meaningful Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
HeraMED (STU:1I4) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for HeraMED's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:1I4 vs ABT, SYK, MDT: Dividend Yield % Comparison
For the Medical Devices subindustry, HeraMED's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HeraMED Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, HeraMED's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where HeraMED's Dividend Yield % falls into.
HeraMED (STU:1I4) has a Dividend Yield % of 0.00% as of Jun. 29, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on HeraMED and its competitors. According to the industry distribution chart, HeraMED ranks #999999 out of 329 companies in the Medical Devices & Instruments industry.
Is HeraMED's Dividend Yield % too high?
HeraMED's current Dividend Yield % is 0.00%. Based on the distribution chart, HeraMED ranks #999999 out of 329 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does HeraMED's Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HeraMED ranks #999999 out of 329 companies for Dividend Yield %. This places HeraMED in the lower half of its industry. The industry median Dividend Yield % is 1.98. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 1.98, based on 329 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on HeraMED and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HeraMED's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeraMED stock overvalued right now?
Based on GuruFocus' analysis, HeraMED (STU:1I4) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.01, compared to a current price of €0.02 — trading 110% above its estimated fair value. The current Dividend Yield % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For HeraMED (STU:1I4), the current Dividend Yield % is 0.00% as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HeraMED Ltd is a medical data and technology company providing the digital transformation of maternity care by revolutionizing the prenatal and postpartum experience with its hybrid maternity care platform. It offers a proprietary platform that utilizes hardware and software to reshape the Doctor/Patient relationship using its clinically validated in-home foetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence. Its offering, HeraCARE, has been engineered to offer a fully integrated maternal health ecosystem designed to deliver care at a lower cost, ensure expectant mothers are engaged, informed and well-supported, and allow healthcare professionals to provide the care and enable early detection and prevention of potential risks.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:1I4 has been successfully added to your 